Iodine-125 seed implantation in the treatment of malignant tumors

Malignant tumors are major causes of morbidity and mortality in China. Despite advances in surgical, radiological, chemotherapeutic, molecular targeting, and immunotherapeutic treatments, patients with malignant tumors still have poor prognoses. Low-dose-rate brachytherapy, specifically (125)I seed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Pan, Huang, Jianwen, Zhang, Yanling, Guo, Huanqing, Chen, Guanyu, Zhang, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Journal of Interventional Radiology Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577067/
https://www.ncbi.nlm.nih.gov/pubmed/37846333
http://dx.doi.org/10.1016/j.jimed.2023.07.006
_version_ 1785121247051382784
author Hu, Pan
Huang, Jianwen
Zhang, Yanling
Guo, Huanqing
Chen, Guanyu
Zhang, Fujun
author_facet Hu, Pan
Huang, Jianwen
Zhang, Yanling
Guo, Huanqing
Chen, Guanyu
Zhang, Fujun
author_sort Hu, Pan
collection PubMed
description Malignant tumors are major causes of morbidity and mortality in China. Despite advances in surgical, radiological, chemotherapeutic, molecular targeting, and immunotherapeutic treatments, patients with malignant tumors still have poor prognoses. Low-dose-rate brachytherapy, specifically (125)I seed implantation, is beneficial because of its high local delivery dose and minimal damage to surrounding tissues. Consequently, it has gained increasing acceptance as a treatment modality for various malignant tumors. In this study, we explored the fundamental principles, clinical applications, and new technologies associated with (125)I radioactive seed implantation.
format Online
Article
Text
id pubmed-10577067
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Shanghai Journal of Interventional Radiology Press
record_format MEDLINE/PubMed
spelling pubmed-105770672023-10-16 Iodine-125 seed implantation in the treatment of malignant tumors Hu, Pan Huang, Jianwen Zhang, Yanling Guo, Huanqing Chen, Guanyu Zhang, Fujun J Interv Med Article Malignant tumors are major causes of morbidity and mortality in China. Despite advances in surgical, radiological, chemotherapeutic, molecular targeting, and immunotherapeutic treatments, patients with malignant tumors still have poor prognoses. Low-dose-rate brachytherapy, specifically (125)I seed implantation, is beneficial because of its high local delivery dose and minimal damage to surrounding tissues. Consequently, it has gained increasing acceptance as a treatment modality for various malignant tumors. In this study, we explored the fundamental principles, clinical applications, and new technologies associated with (125)I radioactive seed implantation. Shanghai Journal of Interventional Radiology Press 2023-07-22 /pmc/articles/PMC10577067/ /pubmed/37846333 http://dx.doi.org/10.1016/j.jimed.2023.07.006 Text en © 2023 Shanghai Journal of Interventional Radiology Press. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Hu, Pan
Huang, Jianwen
Zhang, Yanling
Guo, Huanqing
Chen, Guanyu
Zhang, Fujun
Iodine-125 seed implantation in the treatment of malignant tumors
title Iodine-125 seed implantation in the treatment of malignant tumors
title_full Iodine-125 seed implantation in the treatment of malignant tumors
title_fullStr Iodine-125 seed implantation in the treatment of malignant tumors
title_full_unstemmed Iodine-125 seed implantation in the treatment of malignant tumors
title_short Iodine-125 seed implantation in the treatment of malignant tumors
title_sort iodine-125 seed implantation in the treatment of malignant tumors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577067/
https://www.ncbi.nlm.nih.gov/pubmed/37846333
http://dx.doi.org/10.1016/j.jimed.2023.07.006
work_keys_str_mv AT hupan iodine125seedimplantationinthetreatmentofmalignanttumors
AT huangjianwen iodine125seedimplantationinthetreatmentofmalignanttumors
AT zhangyanling iodine125seedimplantationinthetreatmentofmalignanttumors
AT guohuanqing iodine125seedimplantationinthetreatmentofmalignanttumors
AT chenguanyu iodine125seedimplantationinthetreatmentofmalignanttumors
AT zhangfujun iodine125seedimplantationinthetreatmentofmalignanttumors

Ejemplares similares